PMC:7601109 / 795-1019
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T7 | 202-212 | Disease | denotes | sarcopenia | http://purl.obolibrary.org/obo/MONDO_0006516 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T81360 | 30-31 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T83052 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T91336 | 180-183 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 175-179 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 21-223 | Sentence | denotes | Although a few pharmacological agents (e.g., bimagrumab, sarconeos, and exercise mimetics) are being explored in different stages of trials, not a single drug has been approved for sarcopenia treatment. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
34 | 66-76 | Chemical | denotes | bimagrumab | MESH:C000596367 |
44 | 202-212 | Disease | denotes | sarcopenia | MESH:D055948 |